Dr. Raman on Hematuria in Urothelial Cancer

Jay D. Raman, MD
Published: Monday, May 15, 2017



Jay D. Raman, MD, professor of Surgery and chief of the Division of Urology at Penn State Milton S. Hershey Medical Center, discusses hematuria in patients with urothelial carcinoma.

Every patient with micro- or macrohematuria has the concern that it could be caused from cancer. However, one of the challenges is determining which patients with hematuria have a significant cancer.

Cxbladder Resolve is a tool that helps better stratify those who are at a higher risk for more significant bladder cancer and get them checked in a more timely manner, explains Raman.
 


Jay D. Raman, MD, professor of Surgery and chief of the Division of Urology at Penn State Milton S. Hershey Medical Center, discusses hematuria in patients with urothelial carcinoma.

Every patient with micro- or macrohematuria has the concern that it could be caused from cancer. However, one of the challenges is determining which patients with hematuria have a significant cancer.

Cxbladder Resolve is a tool that helps better stratify those who are at a higher risk for more significant bladder cancer and get them checked in a more timely manner, explains Raman.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Oncology Best Practice™: Choosing Therapies for Patients with EGFR-Mutant Lung Cancers: More Options... More Decisions... Better OutcomesFeb 28, 20182.0
Clinical Vignette Series: 34th Annual Chemotherapy Foundation Symposium: Innovative Cancer Therapy for Tomorrow®Feb 28, 20182.0
Publication Bottom Border
Border Publication
x